AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters
AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China’s southern…
This Analyst Believes Precigen’s Non-Healthcare Divesture Removes Financial Overhang
Yesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS.
T2 Biosystems Shares Slide As Interim Q2 Sales Trail Consensus
T2 Biosystems Inc (NASDAQ:TTOO) expects Q2 FY22 revenues of $5.8 million – $6.1 million, below the consensus of $6.87 million.…
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new functional data across multiple studies from the SRP-9001 (delandistrogene moxeparvovec) program for Duchenne muscular dystrophy. …
Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants
Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing. IMM-BCP-01…
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours:
InflaRx’s Stock Gains Following FDA Fast Track Status To Skin Disease Drug
The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).
FDA Temporarily Suspends Banning Order On Juul’s E-Cigarettes
The FDA temporarily suspended its ban on sales of the popular e-cigarette maker Juul, backed by Altria Group Inc
Traders Circulate NYT Article Titled ‘Will There Be Enough Monkeypox Vaccine?’
https://www.nytimes.com/2022/07/01/health/monkeypox-vaccine-bavarian-nordic.html